Promius Pharma has a new PSA on migraines, building on its campaign to help migraine sufferers recognize many different types of migraine symptoms.
Good news for Seattle Genetics and Takeda: Adcetris hit its goal in a Hodgkin lymphoma trial. Not so good? It didn't beat a standard regimen by much.
The FDA has approved Portola Pharmaceuticals’ factor Xa inhibitor Bevyxxa, but now the company is facing plenty of challenges as it gets the drug off the…
Can smartphones upend commerce in biopharma? AstraZeneca thinks they might. That's why it's in an AI pilot project that’s more healthcare than pharma.
Pharma pulled in big Lions Health audiences with play-by-play case studies and frank talk. Dying commercial model? Creepy big data? Yes, and more.
Cannes means creativity in the advertising world, but pharma is still sitting on the sidelines.
The positive data for Roche’s Ocrevus keep on coming.
It’s a two-fer for McCann Health. The agency won Cannes Lions Health network advertising agency of the year for the second year in a row.
Shire nabbed FDA approval Wednesday for its new long-acting ADHD drug Mydayis, and it's targeting $500 million in sales by 2020.
After scoring impressive numbers with its science-focused TV ad, Pfizer is preparing to launch another next month starring one of its own scientists.